Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KDM6B | O15054 | 1/20 | 0.36 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.36 |
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.36 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.36 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278 | 0.93 | GPR84 (0.44) | BRS3GPR84ALDH1A1 | |
| SCHEMBL9425091 | 0.88 | BRS3 (0.38) | BRS3MEN1POLBKMT2ANPSR1 | |
| SCHEMBL1691973 | 0.84 | BRS3 (0.43) | BRS3MEN1POLBKMT2AHRH3 | |
| SCHEMBL6948633 | 0.82 | — | — | |
| SCHEMBL8326405 | 0.80 | BRS3 (0.42) | BRS3MEN1POLBKMT2AHRH3 | |
| SCHEMBL28063353 | 0.78 | GPR84 (0.49) | BRS3GPR84 | |
| SCHEMBL8129825 | 0.78 | HRH3 (0.35) | BRS3HRH3SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL27458278 | 0.77 | GPR84 (0.42) | GPR84ALDH1A1 | |
| SCHEMBL6251513 | 0.76 | HRH3 (0.38) | BRS3MEN1POLBKMT2AHRH3 | |
| SCHEMBL652534 | 0.76 | PI4KA (0.43) | GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7053524-A | — | — | None | — | — | JP | disclosed |
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-21 | — | — | US | disclosed |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-08 | — | — | US | disclosed |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-01 | — | — | US | disclosed |
| US-20250381514-A1 | METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-12-18 | — | — | US | disclosed |
| US-12459862-B2 | Cement paste composition | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-04 | — | — | US | disclosed |
| US-20250334008-A1 | METHOD FOR TREATING A WELL BORE FOR DEHYDROSULFURIZATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-10-30 | — | — | US | disclosed |
| WO-1992000068-A1 | SUBSTITUTED HISTIDINES | SMITHKLINE BEECHAM CORPORATION (US) | 1992-01-09 | — | — | WO | disclosed |
| EP-0437103-A2 | Substituted 5-(alkyl)carboxamide imidazoles | SMITHKLINE BEECHAM CORPORATION (US) | 1991-07-17 | — | — | EP | disclosed |
| CN-1052672-A | Benzofuran derivative | GLAXO GROUP LTD (GB) | 1991-07-03 | — | — | CN | disclosed |
| EP-0434249-A2 | Benzofuran derivatives | GLAXO GROUP LIMITED (GB) | 1991-06-26 | — | — | EP | disclosed |
| EP-0425211-A1 | Substituted 5-((tetrazolyl)alkenyl)-imidazoles | SMITHKLINE BEECHAM CORPORATION (US) | 1991-05-02 | — | — | EP | disclosed |
| EP-0403158-A2 | Imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0403159-A2 | Imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0028833-B1 | IMIDAZOLE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1984-01-25 | — | — | EP | disclosed |
| US-4340598-A | Hypotensive imidazole derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-07-20 | — | — | US | disclosed |
| EP-0028833-A2 | Imidazole derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | HMOX2, HMOX1, SCO2 | BRS3 3890/4885MEN1 1469/4885POLB 951/4885 |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | TST, SOD1, SAMM50 | BRS3 3399/4885MEN1 3039/4885POLB 1698/4885 |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | SAMM50, SOD1, HNRNPH3 | BRS3 4353/4885MEN1 4092/4885POLB 1153/4885 |
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | SAMM50, SRSF1, GTF2F1 | BRS3 2985/4885MEN1 3915/4885POLB 2388/4885 |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | SOD1, MAFG, HMOX2 | BRS3 2959/4885MEN1 2497/4885POLB 1879/4885 |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IPO8, SLC39A11, SLC2A8 | BRS3 3772/4885MEN1 2712/4885POLB 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.